MedPath

Viatris Inc.

Viatris Inc. logo
🇺🇸United States
Ownership
Public
Established
2020-11-16
Employees
38K
Market Cap
$13.9B
Website
http://www.viatris.com

Heron Therapeutics Settles Patent Litigation with Mylan for CINVANTI and APONVIE

Heron Therapeutics has reached a settlement agreement with Mylan Pharmaceuticals to resolve ongoing patent litigations related to CINVANTI and APONVIE injectable emulsions.

FDA Panel Rejects Lexicon's Zynquista for Type 1 Diabetes

An FDA advisory committee voted against approving Lexicon's Zynquista (sotagliflozin) as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD).

© Copyright 2025. All Rights Reserved by MedPath